Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio Key International (BKYI) Non Operating Income (2016 - 2025)

Bio Key International (BKYI) has disclosed Non Operating Income for 16 consecutive years, with -$72659.0 as the latest value for Q3 2025.

  • Quarterly Non Operating Income rose 54.17% to -$72659.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$391991.0 through Sep 2025, down 297.67% year-over-year, with the annual reading at -$312649.0 for FY2024, 283.41% down from the prior year.
  • Non Operating Income hit -$72659.0 in Q3 2025 for Bio Key International, up from -$83546.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $127545.0 in Q3 2023 to a low of -$1.8 million in Q4 2022.
  • Historically, Non Operating Income has averaged -$132890.9 across 5 years, with a median of -$42063.0 in 2022.
  • Biggest five-year swings in Non Operating Income: soared 53393.13% in 2023 and later crashed 6998.96% in 2025.
  • Year by year, Non Operating Income stood at -$29701.0 in 2021, then tumbled by 6005.23% to -$1.8 million in 2022, then skyrocketed by 104.09% to $74196.0 in 2023, then tumbled by 288.53% to -$139879.0 in 2024, then soared by 48.06% to -$72659.0 in 2025.
  • Business Quant data shows Non Operating Income for BKYI at -$72659.0 in Q3 2025, -$83546.0 in Q2 2025, and -$95907.0 in Q1 2025.